Nicotine Replacement Therapy Market – Global Industry Analysis and Forecast (2023-2029)


Global Nicotine Replacement Therapy Market size was valued at US$ 59.57 Bn in 2022 and the total revenue is expected to grow at 15.90% through 2023 to 2029, reaching nearly US$ 167.35 Bn .

Nicotine Replacement Therapy Market Overview:

Cigarette smoking is a chronic health concern that affects people all over the world. The negative economic and health impacts of smoking have received more attention. Tobacco contains nicotine, which is addictive, and tobacco use almost always results in nicotine addiction. Nicotine replacement therapy (NRT) products and medicines are the most common smoking cessation aids, and they can be used with counseling and psychotherapy. During the process of quitting smoking, however, some nicotine withdrawal symptoms such as anxiety and irritability are noted, leading to the person's resumption of smoking.Nicotine Replacement Therapy Market To know about the Research Methodology :- Request Free Sample Report

Market Dynamics:

The rise in Nicotine Replacement therapy can be linked to a growing number of technical improvements as well as a surge in the number of persons who use nicotine replacement treatment (NRT). Growing public awareness of the effects of tobacco is likely to be a major driver of the industry. Globally, the number of individuals who smoke is increasing and has already reached 1.4 billion. People are opting for smoking cessation therapy as a result of government measures such as the "affordable care act," provisions, and campaigns to raise knowledge about the detrimental effects of smoking on health through counseling. In 2022, % of the 33.9 million smokers in the U. S. attempted to quit.

Scientific modifications in the nicotine replacement treatment market are progressing, increasing the number of persons who are shifting to sophisticated products. The popularity of NRT is anticipated to be assisted by innovations such as heat-not-burn products, flavored chewing gums, and lozenges. Tobacco companies such as British American Tobacco have developed smokeless and less toxic alternatives. When opposed to traditional cigarettes, these advances have a flexible range of efficacy and are acceptable in society, pushing their acceptance and enhancing market growth.

The prohibition on e-cigarettes, on the other extreme, is one of the most significant challenges to the market's expansion. The Indian government, for example, prohibited the import, manufacture, and sale of e-cigarettes in September 2021. India is a country with approximately 100 million smokers, so this factor has huge market potential. Other countries, including Mexico, Brazil, Malaysia, and Thailand, have prohibited the use, import, and manufacture of e-cigarettes. By 2025, over 20 countries will have restricted the use of e-cigarettes. The market's growth is likely to be harmed as a result of this.

Nicotine Replacement Therapy Market Segment Analysis:

The E-cigarettes segment is dominating the Product Type segment of the Global Nicotine Replacement Therapy Market:

In 2022, e-cigarettes had the highest market share of 52.23 %. E-cigarettes are becoming increasingly popular, and they are commonly recognized in the majority of nations. They have an adherence rate of around 17%, which is greater than the average abstinence rate of 9.7% for comparable NRT products. E-cigarettes were used by 3.2 % of individuals in the Us in 2022.

According to the Wiley Journal, 18 % who use patches in combination with another kind of NRT can quit smoking in 2022, whereas 14 % can quit using only one type of NRT. According to the research, goods with a greater nicotine content (4 mg) are more likely to provide beneficial effects than those with a dilute solution (2 mg). further, there are various tobacco favor gums such as Chewing Tobacco, sublingual tablets, nicotine gums and lozenges, and various others stimulating the market expansion in the future.

The offline segment is considered to supplement the growth of the Global Nicotine Replacement Therapy Market.

The offline sector will account for 83.9 % of revenue in 2022. The accessibility of Nicotine Replacement Therapy (NRT) items like transdermal patches, gels, gums, e-cigarettes, and heated tobacco products at big stores such as retail pharmacies and Walmart Stores etc. has supported the segment's development. Furthermore, hospital collaborations with these chains aid in the growth of the firm. The internet industry is expected to grow at the fastest rate throughout the forecasted timeframe. The comfort, flexibility, and convenience provided by online pharmacy purchases are significant factors propelling the business. Discounts offered by internet pharmacies are also likely to fuel category growth.

Regional Insights:

In 2022, North America had a significant market share. The growing incidence of smoking-related problems and the rise in the number of beneficial government efforts, together with rising acceptance of e-cigarettes and heated tobacco, are projected to boost the North American market's growth. The dominating countries of North America are Canada, Mexico, and US., and the US is leading among all.

The U. S. Food and Drug Administration (FDA) approved the sale and distribution of Philip Morris Products S.A.'s IQOS Tobacco Heating System in April 2021. The product is an electrical machine that produces aerosols by heating prefilled tobacco sticks. Furthermore, GlaxoSmithKline plc. launched Nicorette, a mint-flavored nicotine lozenge, as an over-the-counter medication in May 2021. Hence, rapid innovations and product launches by market players in the US are likely to fuel the growth of the market in the forecast period.

The objective of the report is to present a comprehensive analysis of the Global  Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global Nicotine Replacement Therapy Market dynamics, structure by analyzing the market segments and project the Global Nicotine Replacement Therapy Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Nicotine Replacement Therapy Market make the report investor’s guide.

Nicotine Replacement Therapy Market Scope: Inquire before buying






Nicotine Replacement Therapy Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US$ 59.57 Bn.




Forecast Period 2023 to 2029 CAGR:
15.90%
Market Size in 2029:
US$ 167.35 Bn.




 Segments Covered:
by Specimen
cotine Replacement Therapy
Inhalers
Gum
Transdermal Patches
Sublingual Tablets
Lozenges
Others
E-cigarettes
Heat-not-burn Tobacco Products




by Distributions Channels
Offline
Online






Nicotine Replacement Therapy Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina and Rest of South America)

Nicotine Replacement Therapy Market Key Players are:

1. Philip Morris Products S.A. (Altria Group)
2. British American Tobacco p.l.c.
3. Japan Tobacco, Inc.
4. Imperial Brands
5. Glenmark
6. Fertin Pharma
7. Cipla Inc.
8. Pfizer Inc.
9. Johnson & Johnson Services, Inc
10.GlaxoSmithKline plc
11.McNeil AB, NJOY, Inc.
12.Novartis International AG
13.Revolymer PLC
14.Takeda Pharmaceutical Co., Ltd.
15.Perrigo Company Plc
16.Pierre Fabre SA, Laboratories

Frequently Asked Questions:

1. Which region has the largest share in Global Nicotine Replacement Therapy Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Nicotine Replacement Therapy Market?
Ans: The Global Nicotine Replacement Therapy Market is expected to growing at a CAGR of 15.90% during forecast period 2023-2029.

3. What is scope of the Global Nicotine Replacement Therapy market report?
Ans: Global Nicotine Replacement Therapy Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Nicotine Replacement Therapy market?
Ans: The important key players in the Global Nicotine Replacement Therapy Market are – Philip Morris Products S.A. (Altria Group), British American Tobacco p.l.c., Japan Tobacco, Inc., Imperial Brands, Glenmark, Fertin Pharma, Cipla Inc., Pfizer Inc., Johnson & Johnson Services, Inc, GlaxoSmithKline plc, McNeil AB, NJOY, Inc., Novartis International AG, Revolymer PLC, Takeda Pharmaceutical Co., Ltd., Perrigo Company Plc, Pierre Fabre SA, and Laboratories.

5. What is the study period of this market?
Ans: The Global Nicotine Replacement Therapy Market is studied from 2022 to 2029. 




1. Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Nicotine Replacement Therapy Market Size, by Market Value (US$ Bn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2022
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Nicotine Replacement Therapy Market
3.4. Geographical Snapshot of the Nicotine Replacement Therapy Market, By Manufacturer share
4. Global Nicotine Replacement Therapy Market Overview, 2022-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porter Five Forces Analysis
4.1.6.1. The threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. The threat of Substitute Grades
4.1.6.5. The intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Nicotine Replacement Therapy Market
5. Supply Side and Demand Side Indicators
6. Global Nicotine Replacement Therapy Market Analysis and Forecast, 2022-2029
6.1. Global Nicotine Replacement Therapy Market Size & Y-o-Y Growth Analysis.
7. Global Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
7.1. Market Size (Value) Estimates & Forecast By Specimen, 2022-2029
7.1.1. Nicotine Replacement Therapy
7.1.1.1. Inhalers
7.1.1.2. Gum
7.1.1.3. Transdermal Patches
7.1.1.4. Sublingual Tablets
7.1.1.5. Lozenges
7.1.1.6. Others
7.1.2. E-cigarettes
7.1.3. Heat-not-burn Tobacco Products
7.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
7.2.1. Offline
7.2.2. Online
8. Global Nicotine Replacement Therapy Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
9.1. Market Size (Value) Estimates & Forecast By Specimen, 2022-2029
9.1.1. Nicotine Replacement Therapy
9.1.1.1. Inhalers
9.1.1.2. Gum
9.1.1.3. Transdermal Patches
9.1.1.4. Sublingual Tablets
9.1.1.5. Lozenges
9.1.1.6. Others
9.1.2. E-cigarettes
9.1.3. Heat-not-burn Tobacco Products
9.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
9.2.1. Offline
9.2.2. Online
10. North America Nicotine Replacement Therapy Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
11.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
11.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
12. Canada Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
12.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
12.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
13. Mexico Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
13.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
13.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
14. Europe Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
14.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
14.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
15. Europe Nicotine Replacement Therapy Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
16.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
16.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
17. France Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
17.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
17.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
18. Germany Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
18.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
18.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
19. Italy Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
19.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
19.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
20. Spain Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
20.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
20.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
21. Sweden Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
21.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
21.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
22. CIS Countries Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
22.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
22.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
23. Rest of Europe Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
23.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
23.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
24. Asia Pacific Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
24.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
24.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
25. Asia Pacific Nicotine Replacement Therapy Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
26.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
26.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
27. India Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
27.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
27.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
28. Japan Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
28.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
28.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
29. South Korea Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
29.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
29.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
30. Australia Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
30.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
30.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
31. ASEAN Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
31.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
31.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
32. Rest of Asia Pacific Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
32.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
32.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
33. Middle East Africa Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
33.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
33.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
34. Middle East Africa Nicotine Replacement Therapy Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
35.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
35.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
36. GCC Countries Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
36.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
36.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
37. Egypt Textile Reinforced Concrete e-Market Analysis and Forecasts, 2022-2029
37.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
37.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
38. Nigeria Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
38.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
38.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
39. Rest of ME&A Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
39.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
39.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
40. South America Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
40.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
40.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
41. South America Nicotine Replacement Therapy Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
42.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
42.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
43. Argentina Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
43.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
43.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
44. Rest of South America Nicotine Replacement Therapy Market Analysis and Forecasts, 2022-2029
44.1. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029
44.2. Market Size (Value) Estimates & Forecast By Distributions Channels, 2022-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Nicotine Replacement Therapy Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment
45.2.2. New Grade Launches and Grade Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment, and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements
45.3. Company Profile: Key Players
45.3.1. Glenmark
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Grade Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Development
45.3.2. Philip Morris Products S.A. (Altria Group)
45.3.3. British American Tobacco p.l.c.
45.3.4. Japan Tobacco, Inc.
45.3.5. Imperial Brands
45.3.6. Fertin Pharma
45.3.7. Cipla Inc.
45.3.8. Pfizer Inc.
45.3.9. Johnson & Johnson Services, Inc
45.3.10. GlaxoSmithKline plc
45.3.11. McNeil AB, NJOY, Inc.
45.3.12. Novartis International AG
45.3.13. Revolymer PLC
45.3.14. Takeda Pharmaceutical Co., Ltd.
45.3.15. Perrigo Company Plc
45.3.16. Pierre Fabre SA, Laboratories
46. Primary Key Insights
  • INQUIRE BEFORE BUYING